Cargando…
Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction
BACKGROUND: Little is known about the role of interleukin (IL) in patients with acute myocardial infarction (MI), especially soluble IL-2 receptor (sIL-2R) and IL-8. We aim to evaluate, in MI patients, the predictive value of serum sIL-2R and IL-8 for future major adverse cardiovascular events (MACE...
Autores principales: | Pan, Kunming, Xu, Chenqi, Chen, Can, Chen, Shuqing, Zhang, Yuqian, Ding, Xiaoqiang, Xu, Xialian, Lv, Qianzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150071/ https://www.ncbi.nlm.nih.gov/pubmed/37139133 http://dx.doi.org/10.3389/fcvm.2023.1110742 |
Ejemplares similares
-
Vancomycin associated acute kidney injury in patients with infectious endocarditis: a large retrospective cohort study
por: Kunming, Pan, et al.
Publicado: (2023) -
Vancomycin Associated Acute Kidney Injury: A Longitudinal Study in China
por: Kunming, Pan, et al.
Publicado: (2021) -
Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation
por: Ma, Jiaxue, et al.
Publicado: (2023) -
Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019) -
The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction
por: Keavney, Bernard
Publicado: (2010)